跳至主要内容
临床试验/CTRI/2023/09/057257
CTRI/2023/09/057257尚未招募4 期

A comparative clinical study to evaluate the efficacy of Triphaladi Kwatha and Aragwadhamrutadi Kwatha in the management of Urdhwaga Amlapitta.

Dr Lubna Sadaf Khan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age limit is from 18 to 60 years irrespective of Gender, Occupation, Religion and Economical condition.
  • 2) Patients with the following symptoms of Urdhwaga Amlapitta for more than 1-2 month will be included according to Madhav Nidana (51/4-6)14 namely,
  • The symptoms of Amlapitta are as,
  • 1. Chhardi (Vomiting)
  • 2. Tikta-Amla-Udgara (Belching- Bitter/ Sour)
  • 3. Shirashoola (Headache)
  • 4. Utklesha/ Hrullas (Nausea)
  • 5. Hruddaha (Burning in chest)

排除标准

  • 1) Pregnant and Lactating women.
  • 2) Patients with severe Vomiting and Diarrhoea and those who cannot take medicine orally.
  • 3) Amlapitta along with other chronic disease and its associated complications.
  • 4) Known case of Diabetes Mellitus.
  • 5) Patients with gastric ulcers.

研究者

发起方
Dr Lubna Sadaf Khan

相似试验